ArticleBiochemia medica2026
Preanalytical study concerning the influence of tube type and centrifugation conditions on the concentration of calprotectin in ascites.
Article in Biochemia medica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Concentration of calprotectin in ascitic fluid has been proposed as the possible diagnostic marker for spontaneous bacterial peritonitis. This study aimed to choose the optimal preanalytical conditions for the determination of the concentration of calprotectin in ascitic fluid. Materials and methods: Study was performed using 20 samples of ascitic fluid of inflammatory etiology. Number of total nucleated (TNC) and polymorphonuclear cells (PMN) were determined on Advia 2120i (Siemens Healthineers). Ascitic samples were collected into three tube types (K2EDTA, tubes with clot activator and Li-heparin tubes) and centrifuged under three different conditions (400xg, 1500xg and 3000xg 15 minutes). Concentration of calprotectin was determined using Bühlmann's turbidimetric assay and potassium and lactate dehydrogenase using standard laboratory methods on Atellica Solution (Siemens Healthineers). Data was evaluated by Friedman test and Spearman's correlation coefficient. Results: The highest concentration of calprotectin was observed in red tubes with clot activator (centrifuged 1500xg 15 minutes; median 0.349 mg/L, IQR 0.094-1.129 mg/L) and the lowest in lavender tubes (centrifuged 3000xg 15 minutes; median 0.109 mg/L, IQR: 0.037-0.850 mg/L). Friedman test showed statistically significant difference between concentration of calprotectin in different preanalytical conditions (P < 0.001). According to the desirable biological variation criteria, differences in calprotectin concentration were clinically significantly different for different preanalytical conditions. Conclusions: To determine the concentration of calprotectin in ascites, we suggest using a test tube with a red cap and centrifugation conditions of 1500xg 15 minutes which is consistent with the relevant national and international guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.